ISO 13485 Quality Management System implementation and maintenance for medical device organizations. Provides QMS design, documentation control, internal auditing, CAPA management, and certification support.
Nonconforming Product Identified
│
▼
Can it be reworked?
│
Yes──┴──No
│ │
▼ ▼
Is rework Can it be used
procedure as is?
available? │
│ Yes──┴──No
Yes─┴─No │ │
│ │ ▼ ▼
▼ ▼ Concession Scrap or
Rework Create approval return to
per SOP rework needed? supplier
procedure │
Yes─┴─No
│ │
▼ ▼
Customer Use as is
approval with MRB
approval
With the FDA's QMSR (effective February 2, 2026) incorporating ISO 13485:2016 by reference, organizations already ISO 13485 certified gain significant advantages:
Area
Pre-QMSR (Dual System)
Post-QMSR (Unified)
Quality Manual
Separate FDA QSR and ISO 13485 references
Single Quality Manual referencing ISO 13485
Design controls
820.30 + ISO 13485 Clause 7.3 (mapped)
ISO 13485 Clause 7.3 (primary)
CAPA
820.100 + ISO 13485 Clause 8.5
ISO 13485 Clause 8.5 (primary)
Document control
820.40 + ISO 13485 Clause 4.2
ISO 13485 Clause 4.2 (primary)
Purchasing
820.50 + ISO 13485 Clause 7.4
ISO 13485 Clause 7.4 (primary)
Audits
Separate FDA and ISO audit tracks
Single audit satisfying both
FDA-Retained Requirements Beyond ISO 13485
Even under QMSR, certain FDA-specific requirements remain. The QMS must address:
FDA Requirement
CFR Reference
ISO 13485 Gap
Action
Complaint handling (medical device reports)
21 CFR 820.198
Clause 8.2.2 covers complaints but not FDA MDR reporting specifics
Add FDA MDR reporting procedure to complaint handling SOP
Corrections and removals
21 CFR 806
No direct equivalent
Maintain separate procedure for FDA reporting of corrections/removals
Unique Device Identification
21 CFR 830
No UDI clause in ISO 13485
Add UDI procedures to labeling/identification processes
Electronic records and signatures
21 CFR Part 11
No electronic signature requirements
Implement Part 11 compliance for electronic QMS
QMSR Gap Analysis Checklist
Map all existing QSR SOPs to ISO 13485 clause numbers
Identify FDA-retained requirements not covered by ISO 13485
Update Quality Manual scope and references
Retrain staff on ISO 13485 terminology (e.g., "design output" terminology alignment)
Update supplier quality agreements to reference QMSR
Revise internal audit checklist to combined ISO 13485 + FDA requirements
Verify complaint handling addresses both ISO 13485 Clause 8.2.2 and 21 CFR 820.198
Conduct mock audit against QMSR requirements
Digital QMS Implementation
Electronic Document Management System (eDMS) Requirements
Requirement
Implementation
Regulatory Basis
Document version control
Automatic versioning with audit trail
ISO 13485 Clause 4.2.3
Electronic approval workflows
Role-based approval routing with e-signatures
21 CFR Part 11, Annex 11
Access controls
Role-based permissions, segregation of duties
ISO 13485 Clause 4.2.3(c)
Audit trail
Immutable record of all changes with timestamp, user, reason
21 CFR Part 11 §11.10(e)
Backup and recovery
Regular backups with tested restore procedures
ISO 13485 Clause 4.2.4
Training records integration
Link document access to training completion
ISO 13485 Clause 6.2
Obsolete document control
Automatic removal from use with archival
ISO 13485 Clause 4.2.3(e)
Electronic Signatures
Signature Type
Use Case
Technical Requirement
Electronic signature
Document approval, batch release, CAPA closure
Linked to individual, date/time stamped, meaning included
Cross-Reference: ISO 42001 for AI-Enabled Medical Devices
ISO 42001 (AI Management System) Integration with ISO 13485
For medical device organizations developing AI-enabled products, ISO 42001:2023 provides an AI management system framework:
ISO 42001 Clause
ISO 13485 Integration Point
Combined Requirement
4. Context of the organization
Clause 4.1 (General requirements)
Extend QMS scope to include AI-specific processes
5. Leadership
Clause 5 (Management responsibility)
AI governance within quality policy and objectives
6. Planning (AI risk assessment)
Clause 7.1 (Risk management planning)
Extend ISO 14971 risk management to AI-specific risks
7. Support (AI competence)
Clause 6.2 (Human resources)
Add AI/ML competency requirements to training matrix
8. Operation (AI lifecycle)
Clause 7.3 (Design and development)
Integrate AI development lifecycle into design controls
9. Performance evaluation
Clause 8 (Measurement, analysis)
Add AI performance metrics to quality monitoring
10. Improvement
Clause 8.5 (CAPA)
Include AI-related incidents in CAPA scope
AI Lifecycle Integration with Design Controls
ISO 13485 Design Control (Cl. 7.3) ISO 42001 AI Lifecycle
───────────────────────────────── ─────────────────────
Design Input (7.3.3) AI System Requirements
↓ ↓
Design Output (7.3.4) Data Collection & Preparation
↓ Model Architecture & Training
↓ ↓
Design Review (7.3.5) AI Model Validation Review
↓ ↓
Design Verification (7.3.6) Model Verification (accuracy, bias)
↓ ↓
Design Validation (7.3.7) Clinical Validation (real-world performance)
↓ ↓
Design Transfer (7.3.8) Model Deployment & Monitoring
↓ ↓
Design Changes (7.3.9) Model Retraining & Update Control
Supplier Qualification for Software/Cloud Providers
Cloud Service Provider Qualification
Qualification Criterion
Assessment Method
Minimum Requirement
Information security
ISO 27001 certificate or SOC 2 Type II report
Current certification for relevant scope
Data residency
Contractual agreement + architecture review
Data stored in jurisdictions compliant with regulations
Availability SLA
Service agreement review
99.9% uptime minimum for critical systems
Backup and recovery
Architecture review + test results
RPO < 4 hours, RTO < 8 hours for critical systems
Incident notification
Contract clause review
Notification within 24 hours of security incident
Audit rights
Contract clause
Right to audit or receive audit reports
Regulatory compliance
Vendor compliance documentation
GxP-qualified environments (if applicable)
Exit strategy
Data portability assessment
Documented data export capability in standard formats
Assess impact on device/data → CAPA if product affected
Cybersecurity CAPA Process
Step 1: Incident Detection and Containment
→ Activate incident response plan
→ Contain threat and preserve evidence
→ Assess impact on product safety and quality
Step 2: Investigation (Root Cause Analysis)
→ Technical forensic analysis
→ 5 Whys + attack chain reconstruction
→ Identify QMS process failures that enabled the incident
→ Assess whether product quality was affected
Step 3: Corrective Actions
→ Technical: patch vulnerability, update security controls
→ Process: update SOPs, access controls, monitoring
→ People: security awareness training
→ Product: assess need for field safety corrective action (FSCA)
Step 4: Preventive Actions
→ Threat modeling review for similar attack vectors
→ Security control gap analysis
→ Supply chain security review (if applicable)
→ Update cybersecurity risk assessment
Step 5: Effectiveness Verification
→ Penetration testing to verify fix
→ Monitoring for recurrence (90-day window)
→ Review of updated security metrics
→ Close CAPA with evidence of effectiveness
Step 6: Regulatory Reporting (if required)
→ MDR vigilance report (if patient safety affected)
→ FDA MedWatch report (if applicable)
→ GDPR breach notification (if personal data involved)
→ NIS2 incident report (if essential entity)
Cross-references: See ../information-security-manager-iso27001/SKILL.md for ISO 27001 incident response procedures, ../fda-consultant-specialist/SKILL.md for FDA QMSR alignment, and ../risk-management-specialist/SKILL.md for cybersecurity risk integration with ISO 14971.
ISO 13485 Enhanced — QMSR, Digital QMS & Cross-Framework Integration
ISO 13485:2016 Alignment with FDA QMSR
With FDA's Quality Management System Regulation (QMSR) effective Feb 2026:
Direct Alignment: FDA now recognizes ISO 13485:2016 as the quality system standard
Single QMS: Organizations can maintain one QMS for both FDA and EU market access
Gap Analysis: Identify differences between current QSR procedures and ISO 13485 requirements
Transition Plan: Map QSR 21 CFR 820 sections to ISO 13485 clauses, update procedures
Cross-reference: See fda-consultant-specialist for detailed FDA requirements
Digital QMS Implementation
Electronic Document Control: Validated electronic document management system (eDMS)
Electronic Signatures: 21 CFR Part 11 / EU Annex 11 compliant e-signatures
Audit Trail: Automated, timestamped, immutable record of all document changes
Cloud QMS Platforms: Qualification requirements for SaaS QMS solutions (IQ/OQ/PQ)
Cross-reference: See quality-documentation-manager for Part 11 compliance
Remote Audit Considerations
Hybrid Audits: Combination of on-site and remote activities (ISO 19011 guidance)
Technology Requirements: Secure video conferencing, screen sharing, document access
Limitations: Physical process observations may require on-site verification
Notified Body Acceptance: Most NBs accept hybrid audits for surveillance and recertification
AI-Enabled Medical Device QMS
ISO 42001 Integration: For organizations developing AI-enabled medical devices
Data Governance: Training data quality per ISO 42001 Annex A.7 within QMS
Model Lifecycle: AI model versioning and change control within existing QMS processes
Cross-reference: See iso42001-ai-management for AI management system requirements
Supplier Qualification for Software/Cloud Providers
Cloud Service Providers: Qualification checklist (SOC 2, ISO 27001, data residency, SLAs)
Open Source Software: Risk assessment for OSS components (licensing, maintenance, vulnerabilities)
SaaS Tools: Validation requirements for SaaS platforms used in QMS processes
SBOM Management: Track software components across the supply chain
Troubleshooting
Problem
Likely Cause
Resolution
Audit checklist generator returns empty output
Clause number not recognized
Use exact clause numbers from ISO 13485:2016 (e.g., 7.3, 4.2.3, 8.5.2). Run with --interactive to see all available clauses.
System audit checklist is very large
--audit-type system includes all clauses
For targeted audits, use --clause or --process flags to generate focused checklists. System audits intentionally cover the full standard.
Gap analysis matrix shows all clauses as "Major" gaps
Assessment conducted against a greenfield organization
Prioritize gaps by regulatory criticality and product safety impact. Address Clauses 4.2, 7.3, 8.2.4, 8.3, and 8.5 first as these require mandatory documented procedures.
QMSR transition mapping unclear
QSR sections not aligned to ISO 13485 clauses
The QMSR (effective Feb 2, 2026) incorporates ISO 13485 by reference. Map QSR 21 CFR 820 sub-parts to ISO 13485 clauses using the QMSR Gap Analysis Checklist in this skill.
Supplier qualification score borderline (60-80)
Supplier meets some criteria but has gaps
Issue conditional approval with documented improvement requirements and a defined reassessment date. Increase monitoring frequency until the supplier exceeds the 80-point threshold.
Process validation protocol incomplete
IQ/OQ/PQ phases not clearly separated
Each qualification phase must have distinct objectives, acceptance criteria, and documented results. Use the Validation Documentation Requirements table as a template for protocol structure.
Design control audit questions not applicable
Organization does not perform design activities
ISO 13485 permits exclusion of Clause 7.3 if the organization does not design products. Document the exclusion justification in the Quality Manual per Clause 4.2.2.
Success Criteria
QMS gap analysis completed against all ISO 13485:2016 clauses with documented current state, gap severity, priority, and remediation actions
All 6 mandatory documented procedures established, trained, and effective (document control, record control, internal audit, NC product, corrective action, preventive action)
Quality Manual approved with justified clause exclusions, process interactions documented, and scope clearly defined
QMSR transition completed: all QSR SOPs mapped to ISO 13485 clauses, FDA-retained requirements addressed, internal audit checklist updated for combined ISO 13485 + FDA requirements
Supplier qualification program operational with category-based assessment (A/B/C), documented scoring, and approved supplier list maintained
Process validation completed for all special processes (IQ/OQ/PQ documented with approved protocols and reports)
Certification audit passed with zero Major nonconformities and a plan to address any Minor findings within 60 days
Scope & Limitations
In Scope:
ISO 13485:2016 QMS implementation from gap analysis through certification
Document control system design (numbering, approval, change control, review schedules)
Internal audit program planning and execution per Clause 8.2.4
Process validation methodology (IQ/OQ/PQ) per Clause 7.5.6
Supplier qualification and monitoring per Clause 7.4
FDA QMSR transition planning and gap analysis
Digital QMS implementation (eDMS, Part 11, Annex 11 requirements)
Remote and hybrid audit methodology
AI-enabled medical device QMS considerations (ISO 42001 integration)
Out of Scope:
Clinical evaluation or clinical investigation management (use regulatory-affairs-head for clinical evidence strategy)
Product-specific design control execution (the skill provides the design control framework, not product-specific design inputs/outputs)
Sterilization validation protocol development (requires product-specific expertise per ISO 11135/11137/17665)
Regulatory submission preparation (use fda-consultant-specialist or mdr-745-specialist)
Post-market surveillance program execution (use risk-management-specialist for post-production risk monitoring)
IT infrastructure or cybersecurity implementation (use infrastructure-compliance-auditor for technical security)